家族性腺瘤性息肉病
Familial adenomatous polyposis
定义 英文原文(暂无中文)
A rare intestinal polyposis syndrome characterized by the development of up to hundreds to thousands of adenomas in the large bowel. It is a multi-system disorder with important extracolonic manifestations.
别名
结直肠腺瘤性息肉病
基本事实
- 遗传方式
- 常染色体显性、常染色体隐性
- 发病年龄
- 成年期
- 患病率
- 1-9 / 100 000
相关基因 1
| 基因 | 名称 | 关联类型 |
|---|---|---|
| APC | APC regulator of Wnt signaling pathway | Disease-causing germline mutation(s) in |
临床表型 45
极常见 99–80%6
- 腺瘤性结肠息肉病 HP:0005227
- 结肠癌 HP:0003003
- 结直肠息肉病 HP:0200063
- 先天性视网膜色素上皮肥大 HP:0007649
- 胃肠道硬纤维瘤 HP:0100245
- 胃肠道新生物 HP:0007378
常见 79–30%7
- 牙列异常 HP:0000164
- 便秘 HP:0002019
- 腹泻 HP:0002014
- 十二指肠息肉 HP:0004783
- 多发性胃息肉 HP:0004394
- 骨瘤 HP:0100246
- 甲状腺结节 HP:0025388
偶见 29–5%10
- 牙骨质形态异常 HP:0100717
- 甲状腺异常 HP:0000820
- 肾上腺皮质腺瘤 HP:0008256
- 血管纤维瘤 HP:0010615
- 十二指肠腺癌 HP:0006771
- 肾上腺肿瘤 HP:0100631
- 牙瘤 HP:0011068
- 甲状腺乳头状癌 HP:0002895
- 多生牙 HP:0011069
- 牙萌出失败 HP:0000706
罕见 <4–1%22
- 小肠腺癌 HP:0040274
- 星形细胞瘤 HP:0009592
- 胆道梗阻 HP:0005230
- 脑肿瘤 HP:0030692
- 胆管癌 HP:0030153
- 室管膜瘤 HP:0002888
- 表皮样囊肿 HP:0200040
- 纤维瘤 HP:0010614
- 甲状腺肿 HP:0000853
- 肝母细胞瘤 HP:0002884
- 甲状腺功能减退症 HP:0000821
- 脂肪瘤 HP:0012032
- 局限性皮损 HP:0011355
- 髓母细胞瘤 HP:0002885
- 胆囊新生物 HP:0100575
- 胰腺腺癌 HP:0006725
- 胰腺炎 HP:0001733
- 毛母质瘤 HP:0030434
- 垂体腺瘤 HP:0002893
- 软组织肿瘤 HP:0031459
- 胃癌 HP:0012126
- 甲状腺炎 HP:0100646
近两年的全球研究 2,225L2
2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-10Abstracts
- 2026-10荟萃分析系统综述开放获取Enhanced recovery after colorectal surgery in patients with inflammatory bowel disease to reduce hospital length of stay: A systematic review and meta-analysis
- 2026-10Support for Disclosure of Hereditary Tumor Risk to Children and Adolescents: A Scoping Review
- 2026-10综述Approaches to thyroid nodules in paediatric cancer predisposition syndromes
- 2026-09Invited Commentary on: Comparison of the outcomes of ileal pouch-anal anastomosis and ileorectal anastomosis for patients with familial adenomatous polyposis: A systematic review and meta-analysis
- 2026-09开放获取Development of an Interpretable Triage Tool for Colorectal Polyp Risk Stratification Within a Population-Based Screening Program: Machine Learning Approach
- 2026-09开放获取Rapidly Progressive Metastatic Sertoli Cell Tumor Associated With an Adenomatous Polyposis Coli Mutation: A Case Report and Literature Review
- 2026-09综述开放获取Engineering Functional Biomaterials for Targeted and Localized Cancer Drug Delivery: A Structure-Property-Performance Design Perspective
- 2026-09Molecular surgery in colorectal cancer: Integrating genomics into operative decision-making
- 2026-09开放获取Somatic Mutation Profile in Normal Tissue Adjacent to Tumor in Colorectal Carcinoma Patients: Functional Effect on Gene Expression and Potential Implications for Precision Medicine
- 2026-09Life expectancy and changing causes of mortality in familial adenomatous polyposis (FAP)
- 2026-09开放获取Levofloxacin enhances 5-fluorouracil efficacy in colorectal cancer by activating the DDR-TP53-mitochondrial apoptosis axis
- 2026-09综述开放获取Villous Architecture in Colorectal Adenomas: Molecular Pathogenesis, Epithelial Plasticity, and Malignant Risk
- 2026-09开放获取Health technology assessment of robotic surgery for rectal cancer in China: protocol for a nationally multicentre prospective cohort study
- 2026-09Risk of desmoid tumor based on APC pathogenic variant location and surgical history in familial adenomatous polyposis: a U.S. community cohort study
- 2026-09病例报告开放获取Concomitant parathyroid hormone-secreting oncocytic adrenocortical carcinoma and parathyroid adenoma
- 2026-09综述开放获取Essential Updates in the Surgical Management of Inflammatory Bowel Disease: Current Topics From 2024 to Mid‐2026
- 2026-09综述开放获取Role of tumor necrosis factor receptor superfamily member 19 in cancer: Diverse functions and therapeutic potential (Review)
- 2026-09开放获取Intensive Endoscopic Resection for Downstaging of Superficial Non-ampullary Duodenal Epithelial Tumor Burden in Familial Adenomatous Polyposis: A Single-center Retrospective Study on Long-term Clinical Outcome
- 2026-09综述开放获取Bridging pediatric and adult neuro-oncology: Insights into adolescents and young adults (AYA) central nervous system tumors
境外已获批用于本病的药物 0L2
欧盟与美国均未检索到已获批用于本病的药物。
尚未获批的在研药物(17 项)
这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。
- Eicosapentaenoic acid欧盟2009-10-08Treatment of familial adenomatous polyposis (FAP)官方记录
- eflornithine欧盟2010-09-20Treatment of familial adenomatous polyposis (FAP)官方记录
- (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-欧盟2022-07-18Treatment of familial adenomatous polyposis (FAP)官方记录
- Lithium carbonate欧盟2022-08-10Treatment of familial adenomatous polyposis (FAP)官方记录
- sirolimus欧盟2025-04-16Treatment of familial adenomatous polyposis (FAP)官方记录
- live attenuated E. Coli expressing Beta catenin shRNA美国2010-12-20Treatment of Familial Adenomatous Polyposis官方记录
- eflornithine美国2011-02-04Treatment of Familial Adenomatous Polyposis官方记录
- eicosapentaenoic acid美国2011-03-08Treatment of familial adenomatous polyposis官方记录
- eflornithine plus sulindac美国2013-01-22Treatment of familial adenomatous polyposis官方记录
- pyrvinium美国2015-01-05Treatment of familial adenomatous polyposis官方记录
- magnesium lysinate bis eicosapentaenoate美国2015-12-23Treatment of familial adenomatous polyposis.官方记录
- encapsulated rapamycin美国2019-03-15Treatment of familial adenomatous polyposis官方记录
- 3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]美国2021-09-28Treatment of familial adenomatous polyposis官方记录
- Microencapsulated Interleukin-10美国2023-09-05Treatment of Familial Adenomatous Polyposis官方记录
- beta-catenin antagonist美国2024-12-10treatment of familial adenomatous polyposis官方记录
- selective dual antagonist of the human prostaglandin E2 (PGE2) recepto美国2025-03-31treatment of familial adenomatous polyposis (FAP)官方记录
- potent, ATP-competitive small molecule inhibitor of glycogen synthase 美国2026-05-22treatment of familial adenomatous polyposis官方记录
数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。
在中国开展的临床试验 4L2
按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。
登记为可入组 2
- 尚未开始招募NCT04531930Colorectal Adenoma Canceration in FAP中国研究中心 1 个:Shanghai
- 仅邀请入组NCT06649825Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients.中国研究中心 1 个:Shanghai
其他状态的试验(2 项)
- 已完成NCT03333265Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride中国研究中心 1 个:Xi'an
- 已完成NCT05687318A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment中国研究中心 1 个:Beijing
中国境外的在招试验 22L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
CT.gov 报告命中 22 项,此处取回并展示最近的 15 项。
- 尚未开始招募NCT07729371A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
- 尚未开始招募NCT06308445Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis法国
- 招募中NCT07726771Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)英国
- 招募中NCT06641310Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)美国
- 招募中NCT06557733An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis美国
- 尚未开始招募NCT06881303Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion法国
- 招募中NCT07463599Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma美国
- 招募中NCT05630794Testing for Safety and Colorectal Cancer Preventive Effects of ONC201美国
- 招募中NCT06950385Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis丹麦、德国、意大利、荷兰、Puerto Rico、西班牙、美国
- 招募中NCT06538402Ten Versus Fifteen Centimeter Pouch in IPAA Surgery丹麦
- 招募中NCT07066046Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions巴西
- 招募中NCT06614738Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)法国
- 招募中NCT05552755Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)美国
- 招募中NCT05919264FOG-001 in Locally Advanced or Metastatic Solid Tumors澳大利亚、美国
- 招募中NCT04678011A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy荷兰、美国
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)